Ads
related to: tym questionnaire for cancer research treatment fund
Search results
Results From The WOW.Com Content Network
The Cancer Prevention and Treatment Fund analyzes published research, explains contradictory research findings, and helps health professionals, patients, and consumers understand the implications by explaining the findings in reports, published articles, and on its website. The Fund's online cancer hotline answers questions sent by individuals.
The FACT-G is one of the most widely used patient-reported outcomes measures in cancer research along with the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), according to a 2011 systematic review comparing the two instruments. [6]
PRO methods, such as questionnaires, are used in clinical trials or other clinical settings, to help better understand a treatment's efficacy or effectiveness. The use of digitized PROs, or electronic patient-reported outcomes (ePROs), is on the rise in today's health research setting.
One of the main activities of the anticancer Fund is providing the public with scientifically accurate information regarding cancer and treatments. [2] This includes information on the different types of cancer, treatments (both conventional and non-conventional) and other information related to cancer and therapies.
The EORTC research network consists of over 5,500 collaborators from all disciplines involved in cancer treatment and research in more than 930 institutions in 27 countries. Its research spans the entire spectrum from translational and preclinical research to large, prospective, multi-centre, phase III clinical trials that evaluate new cancer ...
The National Cancer Research Institute (NCRI) is a UK-wide partnership between cancer research funders, which promotes collaboration in cancer research.Its member organizations work together to maximize the value and benefit of cancer research for the benefit of patients and the public.
Ad
related to: tym questionnaire for cancer research treatment fund